The diverse clinical manifestations of COVID-19 is emerging as a hallmark of the Severe
Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection. While the initial target …

Cerebral small vessel disease (CSVD) is the leading cause of vascular cognitive impairment
and is associated with COVID-19. However, contributing factors that often accompany CSVD …

The Coronavirus Disease 2019 (COVID-19) outbreak has shocked the whole world with its
unexpected rapid spread. The virus responsible for the disease, the Severe Acute …

The outbreak of the novel and highly infectious severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has resulted in hundreds of millions of infections and millions …

Objectives Earlier diagnosis and the best management of virus‐related, drug‐related or
mixed severe potentially life‐threatening mucocutaneous reactions of COVID‐19 patients …

Objective Risk factors and prognosis of cerebral microbleeding (CMB) complicated acute
large artery atherosclerotic cerebral infarction (ALAACI) patients was controversial. Present …

Neurological manifestations of novel coronavirus disease (COVID-19) are reported to occur
in as much as 37% of the affected patients. These manifestations range from headache and …

Background Cerebral microbleeds are increasingly reported in critical ill patients with
respiratory failure in need of mechanical ventilation and/or extracorporeal membrane …

Background The COVID-19 pandemic has drastically affected everyone in a hit or miss
manner. Since it began, evidence of the neuro-invasive potential of the virus has been …

Introduction Coronavirus 2019 (COVID-19) is known to affect the central nervous system.
Neurologic morbidity associated with COVID-19 is commonly attributed to sequelae of some …